Drawing for HERBIES OREGANO

USPTO serial 99703619

HERBIES OREGANO

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
SCHIMPF, TIMOTHY O
Law office
TMO LAW OFFICE 113

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HERBIES OREGANO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kenneth Motolenich-Salas

Kenneth Motolenich-Salas MOTOSALAS LAW, PLLC16210 North 63rd StreetScottsdale, AZ 85254United States

Goods and services

ClassDescriptionStatusFirst use
005Vitamin oils for human consumption; Dietary supplements for humans; Health food supplements; Dietary supplements; Dietary supplements in the form of capsules; all the foregoing containing oreganoACTIVEMay 9, 2025

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2026RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Apr 1, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Apr 1, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Apr 1, 2026CNSLSUSPENSION LETTER WRITTEN—
Apr 1, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Apr 1, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 1, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 1, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 30, 2026DOCKASSIGNED TO EXAMINER—
Mar 15, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 15, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 15, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance